🇺🇸 FDA
Patent

US 6537560

Melanoma antigens and their use in diagnostic and therapeutic methods

expired A61KA61K2039/5256A61K2039/53

Quick answer

US patent 6537560 (Melanoma antigens and their use in diagnostic and therapeutic methods) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61K2239/31, A61K2239/38